Skip to Accessibility Tools Skip to Content Skip to Footer

GlaxoSmithKline Issues Voluntary Imitrex Recall

GlaxoSmithKline has issued a voluntary recall for two lots of the migraine medication Imitrex (sumatriptan). Pre-filled syringes in the affected lots (C637078 and C632842) may be protruding through the protective packaging, affecting sterility of the product and putting patients at risk for potential infection.

If you have medication from lots C637078 or C632842, do NOT use the medication and return all unused product to your pharmacist. You may also contact GlaxoSmithKline at 1-800-387-7374for more information about returning the product.

Media Advisory: GSK Recalls Two Lots of Migraine Medication: IMITREX Injection. Available at: Accessed November 4, 2013